Avacta Group Plc (LON:AVCT – Get Rating)’s stock price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 124.96 ($1.50) and traded as high as GBX 142 ($1.71). Avacta Group shares last traded at GBX 137.50 ($1.65), with a volume of 1,711,188 shares.
Avacta Group Stock Up 3.4 %
The company has a market cap of £371.07 million, a P/E ratio of -1,375.00 and a beta of 1.61. The company has a quick ratio of 4.96, a current ratio of 5.00 and a debt-to-equity ratio of 13.42. The business’s 50 day moving average is GBX 148.65 and its 200 day moving average is GBX 124.96.
Avacta Group Company Profile
Avacta Group Plc, a clinical stage biopharmaceutical company, develops cancer therapies and diagnostics based on its proprietary Affimer and pre|CISION platforms in the United Kingdom, North America, South Korea, and rest of Asia and Europe. It operates through Diagnostics and Therapeutics segments. The company develops custom Affimer proteins for customer products and in-house diagnostic assays.
- 2 Offshore Drilling Stocks Set to Extract Big Profits
- Three Staples Stocks With Double-Digit Upside Ahead
- Can Investors Trust Consumers to Lift American Outdoor Brands?
- How to Buy High Yielding Dividend Stocks
- Oracle Has Spoken: Shares Fall 5%
Receive News & Ratings for Avacta Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avacta Group and related companies with MarketBeat.com's FREE daily email newsletter.